Form 4: Elanco Director Art A. Garcia Receives Deferred Stock Units

Elanco Animal Health director Art A. Garcia received 18,169 deferred stock units as part of an annual equity award.

Summary

• Art A. Garcia, a director at Elanco Animal Health, received 18,169 deferred stock units on November 29, 2024.
• These units were granted as part of an annual equity award to non-employee members of the company's Board of Directors.
• Following this transaction, Mr. Garcia beneficially owns 80,964 shares of Elanco stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive.

Positives

• The grant of deferred stock units aligns the interests of the non-employee directors with the long-term performance of the company.
• The equity award is a standard practice for compensating board members.

Industry Context

This type of equity grant is a common practice in corporate governance to compensate and incentivize board members.

Comparison to Industry Standards

• Granting deferred stock units to non-employee directors is a standard practice across many publicly traded companies.
• The number of units granted is likely determined by the company's compensation policy and the director's role.
• Similar grants can be seen at companies like Zoetis and IDEXX Laboratories, which also operate in the animal health sector.

Stakeholder Impact

• The grant of stock units aligns the interests of the director with the shareholders.
• This type of compensation is a standard practice and is not expected to have a significant impact on other stakeholders.

Key Dates

Keywords

Elanco Animal Health, Director, Art A. Garcia, Deferred Stock Units, Equity Award, Beneficial Ownership, Board of Directors